
Navneet Puri, PhD
Advertisement
Articles by Navneet Puri, PhD




A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.
Advertisement
Latest Updated Articles
First Vyluma product tackles pediatric myopiaJuly 23rd 2021
Nevakar spins off ophthalmic-only company VylumaJune 1st 2021
Vyluma pipeline focuses on refractive errorJuly 22nd 2021
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Georgia university receives state funding for state's first college of optometry
2
Practical tips and tricks: Drs Jeffrey J. Walline, Erin Tomiyama weigh in on myopia management
3
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
4
Recent study findings may prove previous estimations of retinal cell communication, low-light vision
5

